MINERALYS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.77 USD | +2.82% |
|
+4.67% | +48.49% |
Chart calendar Mineralys Therapeutics, Inc.
a2318a.RYlFK2pbPF1rN7NMVsU289IIQn4_UgoGH44TvF3aDDU.dbASHysNZTUieMAVAqpUrOVQGjoSPk1LXdxj8zaKRU8w6gp_AzwELSJT1A~771155a82121ca8bdafe275dbedcf5cb
Upcoming events on Mineralys Therapeutics, Inc.
Past events on Mineralys Therapeutics, Inc.
| 2024-05-22 12:00 pm | Annual General Meeting |
| 2024-05-15 | BofA Securities Health Care Conference - Fireside Chat |
| 2024-05-09 08:30 am | Q1 2024 Earnings Call |
| 2024-05-09 07:00 am | Q1 2024 Earnings Release |
| 2024-03-21 08:30 am | Q4 2023 Earnings Call |
| 2024-03-21 07:00 am | Q4 2023 Earnings Release |
| 2024-02-08 09:00 am | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 2023-11-29 11:15 am | Evercore ISI HealthCONx Conference |
| 2023-11-16 05:30 am | Jefferies London Healthcare Conference |
| 2023-11-15 12:40 pm | Stifel Healthcare Conference |
| 2023-11-11 11:30 am | American Heart Association Scientific Meeting - Poster No: 4121 |
| 2023-11-07 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-07 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-02 10:00 am | American Society of Nephrology Kidney Conference - Poster No: TH-PO1121 |
| 2023-09-28 09:10 am | Cantor Global Healthcare Conference |
| 2023-09-10 07:45 am | American Heart Association Hypertension Scientific Session - Presentation Number: 113 |
| 2023-09-07 08:45 am | Wells Fargo Healthcare Conference |
| 2023-08-07 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-07 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-09 09:30 am | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -31,5 -31,4 -0.2% | -84,7 -62,4 -35.73% | -148 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -31,5 -45,6 31.04% | -84,7 -77,1 -9.86% | -150 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -29,8 -29,5 -0.93% | -71,9 -86,2 16.61% | -144 |
|
Net income Million USD | Released Forecast Spread | -19,4 | -29,8 -48,0 37.91% | -71,9 -83,3 13.73% | -142 |
|
EPS USD | Released Forecast Spread | -0,36 | -5,77 -4,05 -42.47% | -1,99 -2,28 12.62% | -3,00 |
| Announcement Date | 18/01/23 | 15/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -14,9 -32,8 54.39% | -15,7 -34,0 53.65% | -26,3 -28,7 8.46% | -27,7 -33,9 18.26% | -35,4 -30,4 -16.28% | -37,1 | -38,4 | -40,5 | |
|
EBIT Million USD | Released Forecast Spread | -10,0 -10,0 -0.08% | -14,9 -25,6 41.67% | -15,7 -31,9 50.62% | -26,3 -34,7 24.36% | -27,7 -34,4 19.33% | -35,4 -31,0 -14.08% | -36,1 | -39,2 | -39,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,07 -9,00 -0.81% | -12,6 -30,3 58.34% | -12,1 -27,7 56.22% | -22,8 -42,6 46.57% | -24,4 -35,7 31.75% | -31,5 -29,7 -6.09% | -34,9 | -39,8 | -41,5 |
|
Net income Million USD | Released Forecast Spread | -9,07 -9,00 -0.81% | -12,6 -28,8 56.24% | -12,1 -29,6 58.91% | -22,8 -34,7 34.47% | -24,4 -33,6 27.41% | -31,5 -29,7 -6.17% | -34,8 | -38,3 | -39,6 |
|
EPS USD | Released Forecast Spread | -1,74 -1,72 -1.16% | -0,51 -0,84 39.57% | -0,31 -0,76 59.3% | -0,57 -0,76 25% | -0,61 -0,83 26.06% | -0,70 -0,67 -4.48% | -0,71 | -0,77 | -0,77 |
| Announcement Date | 15/03/23 | 15/05/23 | 07/08/23 | 07/11/23 | 21/03/24 | 09/05/24 | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Mineralys Therapeutics, Inc.
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MLYS Stock
- Calendar Mineralys Therapeutics, Inc.
